Contact us : info@bioworlde.com
Home > Product > Primary Antibodies
Von Willebrand Factor polyclonal antibody BS67414
  • Western blot analysis of Von Willebrand Factor expression in mouse brain (A), rat brain (B), LOVO (C), HCT116 (D) whole cell lysates.
  • Immunohistochemical analysis of Von Willebrand Factor staining in human breast cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
Product NameVon Willebrand Factor polyclonal antibody
Catalog No.BS67414
Swiss-ProtP04275
Host Rabbit
ReactivityHuman, Mouse, Rat
ApplicationsWB, IHC
Application_allWB (1/500 - 1/1000), IHC (1/50 - 1/200)
BiowMW~ 200 kDa
Alternative NameF8VWF; von Willebrand factor; vWF
Purification&PurityThe antibody was purified by immunogen affinity chromatography.
ConjugateUnconjugated
ModificationUnmodification
Browse similar products>>
Size Price
50ul $158
100ul $275
Add to cart My orders
Product Name :
Von Willebrand Factor polyclonal antibody
Background :
VWF (Von Willebrand factor) is a multimeric plasma glycoprotein that promotes adhesion of platelets to sites of vascular injury . Mature circulating VWF is made up of disulfide-bonded multimers that are in a complex with factor VIII . VWF is stored in secretory Weibel-Palade bodies in endothelial cells . It is synthesized as a large precursor protein and undergoes extensive posttranslational modifications including dimerization in the endoplasmic reticulum followed by cleavage of the pro-peptide and multimerization in the Golgi apparatus . VWF is important in hemostasis, and genetic defects in the structure and modification of VWF can cause von Willebrand disease (VWD), the most common congenital bleeding disorder in humans . Alternatively, increased levels of VWF have been shown to be involved in acute coronary thrombosis and are a clinical risk marker for atherosclerosis . VWF has also been shown to have a role in inflammation, functioning as an adhesive site for a variety of leukocyte subsets . Through siRNA experiments and the use VWF-deficient mice, it has also been shown that VWF regulates angiogenesis.
Product :
Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide.
Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Specificity :
Recognizes endogenous levels of Von Willebrand Factor protein.
Immunogen :
KLH-conjugated synthetic peptide encompassing a sequence within the C-term region of human Von Willebrand Factor. The exact sequence is proprietary.
Conjugate :
Unconjugated
Modification :
Unmodification
  • Western blot analysis of Von Willebrand Factor expression in mouse brain (A), rat brain (B), LOVO (C), HCT116 (D) whole cell lysates.
  • Immunohistochemical analysis of Von Willebrand Factor staining in human breast cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
Bioworld Biotech only provide peptides for our antibodies and do not provide additional peptide customization services.

Price/Size :

USD 368/1mg/vial



Tips: 

For phospho antibody, we provide phospho peptide(0.5mg) and non-phospho peptide(0.5mg).

Describe :

Blocking peptides are peptides that bind specifically to the target antibody and block antibody binding. These peptide usually contains the epitope recognized by the antibody. Antibodies bound to the blocking peptide no longer bind to the epitope on the target protein. This mechanism is useful when non-specific binding is an issue, for example, in Western blotting (WB) and Immunohistochemistry (IHC). By comparing the staining from the blocked antibody versus the antibody alone, one can see which staining is specific; Specific binding will be absent from the western blot or IHC performed with the neutralized antibody.

Formula:

Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 10 mg/ml.The purity is >90%,tested by HPLC and MS.

Storage:

The freeze-dried powder is more stable. For short time at 2-8°C. For long term storage store at -20°C. 


Note :

This product is for research use only (RUO only). Not for use in diagnostic or therapeutic procedures.
COPYRIGHT © 2015-2018 Bioworld Technology, Inc. All rights reserved POLYCLONAL AND MONOCLONAL ANTIBODY CENTER